Leptin-induced endothelial dysfunction: A target for therapeutic interventions

Gregory A. Payne, Johnathan D. Tune, Jarrod D. Knudson

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations


Leptin has received much attention since its cloning in 1994. Initially, leptin research centered on satiety, energy balance and sympathetic activation. However, hyperleptinemia has since been identified as an independent risk factor for various cardiovascular pathologies including atherosclerotic coronary artery disease. Over the last decade, multiple studies have implicated leptin as an important mediator in endothelial dysfunction and neointimal hyperplasia, both key steps in the evolution of atherosclerotic vascular changes. Additionally, more recent evidence indicates that paracrine leptin release from perivascular adipose tissue (PVAT) has deleterious effects on the underlying endothelium and vascular smooth muscle cells (SMC), including the coronary circulation. This report reviews pertinent literature on leptin-mediated endothelial dysfunction, SMC proliferation and the role of PVAT-derived leptin with an emphasis on the coronary circulation and discussions of currently proposed molecular mechanisms of PVAT-mediated coronary endothelial dysfunction and neointimal hyperplasia.

Original languageEnglish
Pages (from-to)603-608
Number of pages6
JournalCurrent Pharmaceutical Design
Issue number4
StatePublished - 2014


  • Cardiovascular disease
  • Endothelial dysfunction
  • Endothelium
  • Leptin
  • Metabolic syndrome
  • Perivascular adipose tissue


Dive into the research topics of 'Leptin-induced endothelial dysfunction: A target for therapeutic interventions'. Together they form a unique fingerprint.

Cite this